A detailed history of Clear Street Markets LLC transactions in Cytokinetics Inc stock. As of the latest transaction made, Clear Street Markets LLC holds 22,100 shares of CYTK stock, worth $1.17 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares
22,100
Previous 26,300 15.97%
Holding current value
$1.17 Million
Previous $1.84 Million 35.09%
% of portfolio
0.23%
Previous 0.3%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 26, 2024

SELL
$47.86 - $75.05 $201,012 - $315,210
-4,200 Reduced 15.97%
22,100 $1.2 Million
Q1 2024

May 13, 2024

BUY
$63.75 - $108.06 $1.68 Million - $2.84 Million
26,300 New
26,300 $1.84 Million

Others Institutions Holding CYTK

About CYTOKINETICS INC


  • Ticker CYTK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 94,144,096
  • Market Cap $4.97B
  • Description
  • Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...
More about CYTK
Track This Portfolio

Track Clear Street Markets LLC Portfolio

Follow Clear Street Markets LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clear Street Markets LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clear Street Markets LLC with notifications on news.